Abstract:Objective Congenital heart disease (CHD) is the most common birth defect in humans. The genetic causes for CHD remain largely unknown. Tetralogy of Fallot (TOF) is one major component of conotruncal defects (CTD), a complex CHD induced by abnormal development of the outflow tract. Retinoid X receptor alpha (RXRA), a ligand-dependent transcript factor, plays a critical role in multiple aspects of cardiogenesis including the development of outflow tract (OFT). Taken together, RXRA may be a potential candidate gene of TOF. To date, RXRA gene promoter region has not been analyzed and reported in TOF patients. We hypothesized that the sequence variants within RXRA gene promoter region may change RXRA levels and the development of TOF. In this study, the promoter regions of RXRA gene were genetically analyzed.Methods Case group included DNA samples from patients with TOF, which had been confirmed by cardiac catheterization and surgery. Control group consisted of DNA samples from randomly selected healthy children. Genomic DNA was extracted from peripheral blood. PCR was used to amplify the 1 417 bp promoter region from genomic DNA. PCR products were sequenced by ABI Prism Bigdye system.Results The promoter regions of RXRA gene were genetically analyzed in 213 TOF patients and 500 healthy controls. One novel heterozygous mutation, -1 191A>AG (according to the transcription start site), was found in one TOF patients, but in none of controls. Three novel single-nucleotide polymorphisms, -1287C>CT, -800C>CA and -760C>CT were found in both TOF patients and controls. There were no statistically significant changes in the genotype and allele frequencies of the three SNPs between TOF patients and control group (P>0.05). Several transcription factor binding sites were found within the region containing these single-nucleotide variations by searching http://www.cbrc.jp/research/db/TFSEARCH.html. Conclusions The A at position -1 191 following C, and C at position -800 was followed by G, thus these single-nucleotide variations provided additional candidate cytosines (CpG) for methylation that may enhance the level of gene expression.The sequence variants within RXRA gene promoter may contribute to the TOF etiology by altering the expression levels of RXRA gene.

Tetralogy of Fallot: Variants of MYH6 Gene Promoter and Cellular Functional Analyses

Somatic Mutations in the GATA6 Gene Underlie Sporadic Tetralogy of Fallot

Gata5 Loss-Of-Function Mutations Underlie Tetralogy Of Fallot

Somatic Gata5 Mutations In Sporadic Tetralogy Of Fallot

HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

Association of Promoter Methylation Statuses of Congenital Heart Defect Candidate Genes with Tetralogy of Fallot

Genetic analysis of the RXRA gene promoter in tetralogy of Fallot patients

Whole-exome sequencing revealed novel genetic alterations in patients with tetralogy of Fallot

Promoter Methylation and Expression of the VANGL2 Gene in the Myocardium of Pediatric Patients with Tetralogy of Fallot

Identification of Novel Significant Variants of ZFPM2/FOG2 in Non-Syndromic Tetralogy of Fallot and Double Outlet Right Ventricle in a Chinese Han Population

Investigation of somatic NKX2-5, GATA4 and HAND1 mutations in patients with tetralogy of Fallot.

DNA methylation status of TBX20 in patients with tetralogy of Fallot

DNA Sequencing of TGFβ2 in Sporadic Patients with Tetralogy of Fallot.

Somatic GATA4 mutation contributes to tetralogy of Fallot

Case Report: Tetralogy of Fallot in a Chinese Family Caused by a Novel Missense Variant of MYOM2

TBX20 Loss-of-function Mutation Responsible for Familial Tetralogy of Fallot or Sporadic Persistent Truncus Arteriosus.

CpG island shore methylation of ZFPM2 is identified in tetralogy of fallot samples

Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation

A Novel HAND2 Loss-of-function Mutation Responsible for Tetralogy of Fallot.

Variants of the promoter of MYH6 gene in congenital isolated and sporadic patent ductus arteriosus: case-control study and cellular functional analyses

The Role of Histone Modification and a Regulatory Single-Nucleotide Polymorphism (rs2071166) in the Cx43 Promoter in Patients with TOF.